Orionis Biosciences
Newton, US · Founded 2015 · Delaware LLC · 69 employees on LinkedIn · 5 known investors
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses. It develops therapeutics for cancer, autoimmune diseases, and neurodegenerative disorders through collaborations with industry and academic institutions.
Founders & leadership
Orionis Biosciences was founded in 2015 by Nikolai Kley.
Board
Investors · 5
Reported raises · per SEC filings
Form D private placements$24.5M disclosed across 3 rounds · 2015–2018
▶$19.7MraisedApr 2018 · 9 investors · BiotechnologyRule 506(b)
- Griet Vanpoucke, Ph.D.Director
- Nikolai Kley, Ph.D.Executive Officer, Director
- Steven R. Gullans, Ph.D.Director
- Offering amount
- $25.5M
- Amount sold
- $19.7M
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$750KraisedJan 2017 · 1 investors · BiotechnologyRule 506(b)
- Nikolai Kley, Ph.D.Executive Officer, Director
- Griet Vanpoucke, Ph.D.Director
- Steven R. Gullans, Ph.D.Director
- Offering amount
- $5.3M
- Amount sold
- $750K
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$4MraisedOct 2015 · 4 investors · BiotechnologyRule 506(b)
- Griet Vanpoucke, Ph.D.Director
- Steven R. Gullans, Ph.D.Director
- Nikolai Kley, Ph.D.Executive Officer, Director
- Offering amount
- $5.3M
- Amount sold
- $4M
- First sale
- Sep 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Orionis Biosciences went on to found or lead other companies.
Competitors · 3
by search overlap
Companies competing with Orionis Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Orionis Biosciences do?
- Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses. It develops therapeutics for cancer, autoimmune diseases, and neurodegenerative disorders through collaborations with industry and academic institutions.
- Who founded Orionis Biosciences?
- Orionis Biosciences was founded by Nikolai Kley in 2015.
- Who are Orionis Biosciences's investors?
- Orionis Biosciences's investors include Excel Venture Management, Solari Capital, Solasta Ventures, V-Bio Ventures, Wessel Management.
- How much funding has Orionis Biosciences raised?
- Orionis Biosciences has disclosed $24.5M raised across 3 rounds.
- Where is Orionis Biosciences headquartered?
- Orionis Biosciences is headquartered in Newton, US.